Case Report
Vaginal Angiomyofibroblastoma: A Case Report and Review of Diagnostic Imaging
Table 1
Clinical and pathologic features of AMFB and AA.
| | AMFB | AA |
| Clinical features | | | Age (years) | 16 – 86 (Median 45) | 16 – 70 (Median 37) | Size (cm) | < 5 (0.5 – 23) | >5 (1-60) | Location | Female pelvis and perineum: predominantly vulvar/vaginal | Female pelvis and perineum | Onset | 1 month to 8 years | 1 month – 5 years | Predominantly 1-2 years | Predominantly < 1 year | Recurrence | None reported | 33-72% | Pathology | | | Low-power features | Well-defined | Infiltrative | No entrapment of mucosal glands or nerve bundles | Entrapped mucosal glands and nerve bundles | Alternating hypocellular and hypercellular areas | Stromal cells distributed throughout | Vasculature | Abundant thin-walled vessels, mostly capillary-like | Small to medium-sized vessels, mostly thick-walled or hyalinized | Stromal cells | Abundant | Low cellularity | Spindle, plump spindle, or oval | Thin delicate spindle or stellate | Perivascular aggregation | Mitotic figures typically absent | Mitotic figures typically absent | | Stroma | Mucin-poor, containing delicate, wavy collagen fiber | Myxoid, hyaluronic-acid rich | Immunostaining | | | Desmin | Positive (50-60%) | Positive (Up to 73%) | –SMA | Negative (positive in up to 15%) | Positive | S-100 | Negative | Negative | Vimentin | Positive | Positive | Estrogen receptor | Positive | Positive | Progesterone receptor | Positive | Positive |
|
|